What does peptide molecular weight confirmation reporting include on a lot record?
A molecular weight confirmation is not a single number beside a purity percentage. Peptide molecular weight confirmation reporting should be a closed set of fields that a second analyst can recalculate. The identity block names the material, the lot, the sequence or construct, and the covalent form the theoretical mass describes: termini, disulfides, cyclisation and any intentional modification. If the lot is a salt, state that counter-ions are excluded from the peptide mass unless an adduct was the measured ion. The numerical core is theoretical mass, mass type, observed mass and mass error. Mass type is monoisotopic or average, and it must match on both sides of the comparison. Mixing a monoisotopic calculation with an average observed mass creates a false failure that grows with chain length. The observed-mass field must say whether the number is a neutral deconvoluted mass or a charged ion such as [M+H]+. Leaving a proton in the reported value shifts the comparison by about 1 Da and can fail a tight window even when the sequence is correct. Traceability sits beside the numbers: instrument class, ionisation mode, resolution or a unit-resolution statement, calibrant, acquisition date and raw-file identifier. For matrix-assisted measurements the matrix name is part of the method. Shroff and colleagues showed that matrix choice, including a proton-sponge matrix, changes which metabolites form useful MALDI ions (PMID:19705852). Write the acceptance rule explicitly. State the window in daltons or parts per million, whether it applies to the most abundant ion or to a deconvoluted neutral mass, and what happens when a second species exceeds a stated relative intensity. Unassigned peaks above that intensity belong in an exception row. A missing unit makes the window unusable.
How should theoretical mass be defined before an observed value is compared?
A theoretical mass is only as good as the structure it encodes. Peptide molecular weight confirmation reporting starts by writing that structure so a calculator and a reviewer can follow it. Residue masses should come from a stated table, identified as monoisotopic or average. Show the residue sum, the mass added or removed at each terminus, and the mass change for every intentional modification. Amidation, acetylation, a fatty acyl chain, a disulfide and a cyclic constraint each move the target by a defined number of daltons. Cyclisation is a frequent silent mismatch. Song and colleagues described construction of cyclic peptides through an on-tether sulfonium centre (PMID:36279536). Whatever chemistry is used, the linear precursor and the cyclic product do not share a mass. Quoting the linear formula for a cyclic vial produces a systematic offset equal to the leaving-group loss. Name the covalent form in words, such as cyclic with one disulfide or linear with free thiols, and make the calculator output match that sentence. Qian and colleagues identified fusion partners for extracellular production of recombinant proteins in Escherichia coli (PMID:18727129). If the lot is still the fusion, the theoretical mass is partner plus target, minus residues removed in cloning, plus linkers. If the lot is the cleaved product, omit the partner and state the new termini. Reporting the peptide mass without naming the species makes a correct measurement look like a failure, or lets a fusion contaminant pass as the cleaved product. Fang and colleagues discussed molecular-level precision in high-molecular-weight peptide dendrimers (PMID:34705008). Generation, branching and end-group substitution each add a repeatable increment, so build the theoretical value generation by generation and record the generation. Do not round theory to the nearest integer and then apply a sub-dalton window, because rounding can consume the window.
How do electrospray deconvolution and MALDI-TOF change the reported mass?
The observed mass depends on the transformation applied to the spectrum, and that transformation must be named. Electrospray ionisation usually yields a charge-state envelope. Software deconvolutes it to a neutral mass. Peptide molecular weight confirmation reporting should record the charge states used, the software version, and whether the output is monoisotopic or average. When a separation precedes the analyser, each mass belongs to a peak. Bush and colleagues used high-resolution capillary zone electrophoresis–mass spectrometry to characterise intact proteoforms of interferon-β1 quantitatively (PMID:26641950). A certificate that prints one deconvoluted mass without a peak label implies a homogeneity the data may not show. If two proteoforms are resolved, report both masses, their relative signals, and which species was the intended product. MALDI-TOF batch checks often report [M+H]+ at unit resolution. Do not silently subtract the proton. Either report m/z with the ion assignment, or report a neutral mass and state that the laboratory's stated proton mass was subtracted. Sodium and potassium adducts, about +22 Da and +38 Da relative to [M+H]+, are common. If the base peak is an adduct, say so. Matrix identity remains material, as metabolite MALDI work with a proton-sponge matrix illustrates (PMID:19705852). Calibration is part of the same block. Identify external calibration against a named mix, or internal calibration with a co-spotted standard. Low-mass peptides need the acquired m/z range and a statement that the calibrant bracketed the analyte. Wasinger and colleagues treated low-mass blood peptides from a quantitative proteomic perspective (PMID:26530476). A nominal match is incomplete if the low-mass region was cropped or uncalibrated. Omenn reviewed plasma proteomic profiling strategies that determine which masses are observed, so state whether the spectrum came from the named lot as supplied or from an extract (PMID:16991194).
How should mass error, adducts and modifications be audited on the report?
Mass error is observed mass minus theoretical mass, unless the laboratory states another sign convention. Report the absolute difference in daltons and, for high-resolution data, the relative difference in parts per million. Parts per million equal the dalton error divided by the theoretical mass, multiplied by one million. A fixed dalton window becomes tighter in parts per million as mass rises; a fixed parts-per-million window allows a larger dalton error. A 10 ppm window is 0.02 Da at 2,000 Da and 0.2 Da at 20,000 Da. Fang and colleagues' attention to molecular-level precision in high-molecular-weight peptide dendrimers is a reminder to keep the unit fixed across lots (PMID:34705008). If a dual rule is used, such as the wider of 0.5 Da or 20 ppm, write it in full. Give adducts and modifications their own rows: proposed assignment, theoretical shift, observed shift, relative intensity, and confirmed or tentative status. Oxidation is nominally +16 Da, deamidation nominally +1 Da, and sodium nominally +22 Da relative to [M+H]+. A +16 m/z shift on a doubly charged ion is only +8 Da of molecular mass. Mixing m/z shifts with neutral-mass shifts creates false modification calls. Kay and colleagues reported increased C-peptide immunoreactivity attributable to high-molecular-weight proinsulin rather than to the named immunoassay analyte (PMID:34051096). For a research-lot file the lesson is analytical only: a label, or a selective-assay signal, is not a molecular mass. If the measured mass falls outside the window, record it, mark identity as not confirmed, and keep the spectrum identifier. Print the signed error beside the window so a later lot can be compared without reopening the raw file. List ions above a stated percentage of the base peak and print that threshold on every lot.
How should Australian buyers read a cut-off, a proteoform split and the lot file?
Sometimes molecular weight is a separation rule before a confirming spectrum exists. Chen and colleagues reported host-cell protein analysis in monoclonal antibody products that used molecular weight cut-off enrichment (PMID:31999105). The nominal cut-off, the device, the fraction analysed and any recovery check all change which species remain. A missing high-mass component may have been retained on the membrane rather than absent from the lot. For recombinant material, partner-plus-target is a different mass from the cleaved target (PMID:18727129). If a cut-off is used, say whether the intended species was expected in the filtrate or the retentate. Resolved proteoforms need one row each, not an average. Intact CZE-MS work on interferon-β1 showed that proteoforms can be separated and quantified rather than collapsed to one mass (PMID:26641950). Report migration or retention marker, deconvoluted mass, error against the closest theoretical form, and relative signal. If the certificate header names a single sequence, and two species of similar intensity are present, do not write the header as though one mass confirmed one name. Synthetic short peptides may not need a cut-off device, but they still need an acquired m/z range. Low-mass regions are analytically busy (PMID:26530476). State any software gate that rejected peaks below a signal-to-noise ratio. Match product name, construct code, lot and acquisition date to the vial and to the chromatographic report before accepting a mass. Read theory, including mass type and covalent form, before the observed number and the signed error. A mass match does not state net peptide content, counter-ion fraction, water or endotoxin; those have their own methods. Research peptides supplied in Australia should be documented as research materials. It does not authorise human use, and it does not describe a biological effect.
Frequently asked questions
What is the difference between monoisotopic and average mass on a peptide certificate?
Monoisotopic mass uses the most abundant isotope of each element, so it matches a resolved isotope peak. Average mass uses weighted elemental averages and matches an unresolved envelope. Peptide molecular weight confirmation reporting must use the same type on both sides of the comparison. Mixing them creates a chain-length-dependent error that can look like a sequence failure. The certificate should name the type in the theoretical-mass field and again beside the observed value.
Should a MALDI report quote a protonated ion or a neutral mass?
Either is acceptable if the choice is explicit. Routine MALDI-TOF often measures [M+H]+. Subtracting a proton without saying so shifts the result by about 1 Da. Quote m/z plus the ion assignment, or quote a neutral mass and state the proton mass used. Sodium and potassium adducts should be labelled as adducts, not relabelled as the protonated molecule to force concordance.
What mass-error window should a research laboratory print?
There is no single window for every peptide and instrument. Print the rule the laboratory can actually support with its calibration. High-resolution electrospray data are often judged in parts per million; unit-resolution MALDI data are often judged in daltons. A dual rule, such as the wider of a dalton limit and a parts-per-million limit, must be written in full. A pass stamp without the signed error and the unit is not auditable.
Does a matching molecular weight confirm chromatographic purity?
No. Mass concordance supports identity of the stated covalent structure. Chromatographic peak-area percent is a separate result from a separate method, with its own wavelength, integration rules and reporting threshold. A lot can match theory and still contain co-eluting related substances, or it can look pure by HPLC and fail the mass window. Keep the two results in different fields and do not let one stand in for the other.
How should a cyclic peptide or a fusion construct be described?
Name the covalent form in words and make the arithmetic match. A cyclic product is not the linear precursor; the theoretical mass must include the mass lost on cyclisation. A fusion is partner plus target plus linker, minus any residues removed in cloning. A cleaved lot must omit the partner and state the new termini. Quoting an unspecified peptide mass makes a correct spectrum look like a failure, or hides the wrong species inside a pass.
References
- PMID:19705852 — Proton sponge: a novel and versatile MALDI matrix for the analysis of metabolites using mass spectrometry — Anal Chem — 2009
- PMID:36279536 — Constructing Cyclic Peptides Using an On-Tether Sulfonium Center — J Vis Exp — 2022
- PMID:18727129 — Proteome-based identification of fusion partner for high-level extracellular production of recombinant proteins in Escherichia coli — Biotechnol Bioeng — 2008
- PMID:34705008 — Molecular level precision and high molecular weight peptide dendrimers for drug-specific delivery — J Mater Chem B — 2021
- PMID:26641950 — High Resolution CZE-MS Quantitative Characterization of Intact Biopharmaceutical Proteins: Proteoforms of Interferon-β1 — Anal Chem — 2016
- PMID:26530476 — Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective — Mol Cell Proteomics — 2016
- PMID:16991194 — Strategies for plasma proteomic profiling of cancers — Proteomics — 2006
- PMID:34051096 — Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin — Clin Chem — 2021
- PMID:31999105 — Improved Host Cell Protein Analysis in Monoclonal Antibody Products through Molecular Weight Cutoff Enrichment — Anal Chem — 2020
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
